Omeprazole v ranitidine for prevention of relapse in reflux oesophagitis. A controlled double blind trial of their efficacy and safety.

The aim of this study was to compare recurrence rates of reflux oesophagitis (after endoscopic healing with omeprazole) over a 12 month period of randomised, double blind, maintenance treatment with either daily omeprazole (20 mg every morning; n = 53), weekend omeprazole (20 mg on three consecutive...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Dent, J, Yeomans, N D, Mackinnon, M, Reed, W, Narielvala, F M, Hetzel, D J, Solcia, E, Shearman, D J
Médium: Artigo
Jazyk:Inglês
Vydáno: 1994
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1374738/
https://ncbi.nlm.nih.gov/pubmed/8200548
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky